期刊文献+

药物靶标研究中的功能基因组学 被引量:5

Functional genomics in drug target research
下载PDF
导出
摘要 在人类基因组计划完成以及新的生物技术推动下,传统的药物发现模式正在向基因组学为基础的现代药物发现模式转变。药物靶标的发现,是药物发现途径中最关键的一个环节。该文就目前靶标不同阶段的研究策略和方法做一综述,重点介绍新的生物技术对药物靶标研究所产生的影响并展望未来发展趋势。 Due to the completion of human genome project and the advent of new technologies, the traditional drug discovery is shifting to genomics-based drug discovery. Target discovery is an important first step in drug discovery pipeline. In this review, we critically introduce the strategies and biology technologies for target discovery, especially focus on the likely impact of new technologies in drug target research and speculate the future trend of target research.
作者 王玉 汪海
出处 《中国药理学通报》 CAS CSCD 北大核心 2005年第3期266-268,共3页 Chinese Pharmacological Bulletin
基金 国家"863"计划重大专项基金资助项目(No2002AA2Z3137)
关键词 药物发现模式 生物技术 药物靶标 drug discovery biology technologies drug target
  • 相关文献

参考文献16

  • 1homas Reiss. Drug discovery of the future: the implications of human genome project[J].TRENDS in Biotechnology,2001,19(12):496-9.
  • 2Drews J.Drug discovery:A historical perspective[J].Science,2000,287(5460):1960-4.
  • 3Drews J. Genomics sciences and the medicine of tomorrow[J].Nat Biotechnol,1996,14(11):1516-8.
  • 4Hopkins AL, Groom CR. The druggable genome[J].Nat Rev Drug Discov,2002,1(9):727-30.
  • 5Lindsay MA. Target discovery[J].Nat Rev Drug Discov,2003,2(10):831-7.
  • 6孙建和,陆苹.微生物基因组上药物作用靶位的识别[J].中国药理学通报,2003,19(1):9-12. 被引量:3
  • 7Xinang CC, Chen Y. cDNA microarray technology and its applications[J].Biotechnol Adv,2000,18(1):35-46.
  • 8徐燕丰,胡晋红,朱全刚.蛋白质组学:药理学研究的新动力[J].中国药理学通报,2004,20(8):849-852. 被引量:3
  • 9Hong NA, Kay SA, Glynne RJ. Using mouse forward genetics to define novel target space[J].Targets,2002,1:130-8.
  • 10Dean NM.Functional genomics and target validation approaches using antisense oligonucleotide technology[J].Curr Opin Biotechnol,2001,12(6):622-5.

二级参考文献25

  • 1Pandey A, Mann M. Proteomics to study genes and genomes[J]. Nature,2000,405(6788):837-46.
  • 2Sanchez JC, Converset V, Nolan A et al. Effect of rosiglitazone on the differential expression of diabetes-associated proteins in pancreatic islets of C57Bl/6 lep/lep mice[J]. Mol Cell Proteomics,2002,1(7): 509-16.
  • 3Graves PR, Kwiek JJ, Fadden P et al. Discovery of novel targets of quinoline drugs in the human purine binding proteome[J]. Mol Pharmacol, 2002,62(6):1364-72.
  • 4Poirier F, Pontet M, Labas V et al. Two-dimensional database of a Burkitt lymphoma cell line (DG 75) proteins: Protein pattern changes following treatment with 5′-azycytidine[J]. Electrophoresis, 2001,22(9):1867-77.
  • 5Nakeff A, Sahay N, Pisano M et al. Painting with a molecular brush: Genomic/proteomic interfacing to define the drug action profile of novel solid-tumorselective anticancer agents[J]. Cytometry, 2002,47(1):72-9.
  • 6Kovarova H, Hajduch M, Korinkova G et al. Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine[J]. Electrophoresis,2000,21(17):3757-64.
  • 7Anderson NL, Esquer-Blasco R, Richardson F et al. The effects of peroxisome proliferators on protein abundances in mouse liver[J]. Toxicol Appl Pharmacol,1996,137(1):75-89.
  • 8Edvardsson U, Alexandersson M, Brockenhuus von Lowenhielm H et al. A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643[J]. Electrophoresis,1999, 20(4~5): 935-42.
  • 9Chevalier S, Macdonald N, Tonge R et al. Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumour necrosis factor alpha or the peroxisome proliferator nafenopin[J]. Eur J Biochem,2000,267(15): 4624-34.
  • 10Sinha P, Poland J, Kohl S et al. Study of the development of chemoresistance in melanoma cell lines using proteome analysis[J].Electrophoresis,2003,24(14):2386-404.

共引文献4

同被引文献60

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部